Skip to main content

Table 1 Clinical details and results obtained in the four studied cases

From: Unbalanced chromosome 1 abnormalities leading to partial trisomy 1q in four infants with Down syndrome and acute megakaryocytic leukemia

 

Case 1

Case 2

Case 3

Case 4

Clinical History

persistent anemia since birth

anemia, thrombocytopenia, MDS

anemia, thrombocytopenia, MDS

anemia, thrombocytopenia, MDS

Age of diagnosis

20 months

20 months

17 months

11 months

Sex/Ethnicity

male/non-white

female/white

female/non-white

male/non-white

Diagnosis

August 2005

March 2006

February 2006

May 2005

BM Morphology

Hyper-cellular, 72% blast cells, abnormal nucleoli and blebs

Hyper-cellular, 95% blast cells

Hyper-cellular, 60% blast cells

Hyper-cellular, 80% blast cells, nucleoli and blebs

WBC [ml]

3.8 × 103

13.0 × 106

4.0 × 106

36.7 × 106

Blast cells [%]

45

24

10

43

Platelets count [ml]

90 × 106

26.0 × 106

46 × 106

90 × 106

Final Diagnosis

AML-M7

AML-M7

AML-M7

AML-M7

Immunophenotype

CD33/CD13+; CD7/CD34/CD117+; CD61/CD41+

CD61/CD14+/CD13/CD33+; CD38/CD117+

CD33/CD13+; CD7/CD34+; CD61+

CD33/CD13+; CD7/CD34/CD117+; CD61/CD41+

Cytogenetics G banding

47,XY,der(19)t(1;19) (q24;p13.3),der(20)t(1;20) (q24;q11.2),+21c [13]

48,XX,t(1;16)(q21;q12.1), +der(16)t(9;16)(q13;q12.1), +21c [15]

47,XX,der(17)t(1;17) (q32;p13),+21c [20]

47,XY,-1, add(5)(p14), del(7)(p15), +der(7)t(1;7)(q21;p22), +21c [10]

MCB Banding

47,XY,der(19)t(1;19) (q31;p13.3),der(20)t(1;20) (q31;q12~13.1),r(20) (p11.2q12),+21c [53]/47,XY, der(2)t(2;11)(q37.3;q12~13), der(19)t(1;19)(q31;p13.3), der(20)t(1;20)(q31;q12~13.1),+21c[5]

48,XX,t(1;16)(q31~32;q23), der(5)t(1;5)(q31~32;p13),+der(16)t(16;1;5) (q23;q31~32;p13),+21c

47,XX,der(17)t(1;17) (q32;p13),+ 21c

n.a.

Gata-1 status

no mutation

c.56G > A

c.113 del G

c.201A > G

Treatment

AML BFM 98

AML BFM 98

AML BFM 98

AML BFM 98

Disease status

Dead with disease

Alive in complete remission

Alive in complete remission

Dead in complete remission

  1. Clinical details and results obtained in the four studied AML-M7 with Down syndrome cases are given. Abbreviations: AML = acute myeloid leukemia; AML-M7: acute megakaryoblastic leukemia; BFM: Berlin-Frankfurt-München; BM = bone marrow; n.a. = not available due to lack of material; MDS = myelodysplastic syndrome; WBC: white blood cell count; MCB: multicolor banding